Ernest Mario
Director, Alexza Pharmaceuticals Inc.
Companies
- SOLENO THERAPEUTICS INCBoard member Nov 12, 2014 to Jun 10, 20241
- HYPERION DEFI, INC.Board member Jan 24, 2018 to Nov 22, 20212
- Kindred Biosciences, Inc.Board member Dec 11, 2013 to Jan 22, 20213
- Jasper Therapeutics, Inc.Board member Nov 19, 2019 to Nov 19, 20194
- Tonix PharmaceuticalsBoard member Jan 14, 2013 to Jun 27, 20185
- Chimerix (United States)Board member Apr 10, 2013 to May 21, 20186
- Boston ScientificBoard member Jan 4, 2006 to Nov 17, 20157
- VivusBoard member Apr 27, 2012 to May 30, 20138
- MaxygenBoard member May 31, 2006 to Jun 7, 20129
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- HYPERION DEFI, INC. HYPD382,706 shares10$1.1M at $2.84Nov 17, 2021
- SOLENO THERAPEUTICS INC214,855 shares11Jun 10, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 6, 2024Granted 6,500 shares of SOLENO THERAPEUTICS INC11
- May 21, 2024Exercised 62,000 shares at $4.50 of SOLENO THERAPEUTICS INC12
- Jan 8, 2024Gift 3,523 shares of SOLENO THERAPEUTICS INC13
- Nov 30, 2023Gift 8,700 shares of SOLENO THERAPEUTICS INC14
- Mar 31, 2022Bought 930,000 shares of SOLENO THERAPEUTICS INC15
- Mar 31, 2022Bought 930,000 shares of SOLENO THERAPEUTICS INC15
- Jan 31, 2022Granted 56,338 shares at $0.36 of SOLENO THERAPEUTICS INC16
- Nov 17, 2021Granted 6,963 shares of HYPERION DEFI, INC.10
- Oct 29, 2021Granted 26,888 shares of SOLENO THERAPEUTICS INC17
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARHYPERION DEFI, INC., Board member
- 3
- 4
- 5SEC EDGARTonix Pharmaceuticals, Board member
- 6
- 7SEC EDGARBoston Scientific, Board member
- 8SEC EDGARVivus, Board member
- 9SEC EDGARMaxygen, Board member
- 10
- 11
- 12SEC EDGARForm 4 filed May 23, 2024
- 13SEC EDGARForm 4 filed Jan 10, 2024
- 14SEC EDGARForm 4 filed Dec 4, 2023
- 15SEC EDGARForm 4 filed Apr 4, 2022
- 16SEC EDGARForm 4 filed Feb 2, 2022
- 17SEC EDGARForm 4 filed Nov 2, 2021